Inactive Instrument
Cellivery Therapeutics, Inc. Stock
Stocks
A268600
KR7268600004
Biotechnology & Medical Research
| 1 day | -30.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
CEO | Chief Executive Officer | 58 | 28/08/2014 |
Byung-Hwa Lee
AUD | Comptroller/Controller/Auditor | 62 | 22/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
BRD | Director/Board Member | 58 | 28/08/2014 |
Yung-Ki Baek
BRD | Director/Board Member | 73 | 31/03/2023 |
Hyung Kim
BRD | Director/Board Member | 40 | 29/03/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -30.43% | -75.38% | - | - | 400K | |
| -4.31% | -6.62% | +65.79% | +98.02% | 69.06B | |
| +1.94% | +1.31% | +49.39% | +87.85% | 63.06B | |
| +1.65% | +23.37% | +8.90% | -2.71% | 28.34B | |
| +1.77% | -1.74% | -1.63% | +477.98% | 27.07B | |
| +7.41% | +7.45% | +56.85% | +17.70% | 25.45B | |
| +2.96% | +3.14% | +37.82% | -15.66% | 19.69B | |
| +5.36% | +4.61% | +270.18% | +415.10% | 19.19B | |
| +0.10% | -3.50% | +11.43% | +519.16% | 15.95B | |
| +2.13% | +4.61% | +46.62% | +152.71% | 13.52B | |
| Average | -1.09% | +3.27% | +60.60% | +194.46% | 31.26B | |
| Weighted average by Cap. | +1.12% | +1.66% | +57.07% | +155.08% |
Employees
-
